期刊文献+

系统性红斑狼疮和类风湿关节炎患者的乙型肝炎病毒感染临床分析

Clinical analysis of hepatitis B virus infection in patients with systemic lupus erythematosus and rheumatoid arthritis
在线阅读 下载PDF
导出
摘要 目的探讨系统性红斑狼疮(SLE)、类风湿关节炎(RA)患者乙型肝炎病毒(HBV)的感染情况。方法收集确诊系统性狼疮性346例、类风湿关节炎294例为病例组,收集其HBV血清学标记物结果,记录其临床资料、相关实验室检查数据。结果:健康人对照组(同年体检的健康人群12 779人)HBs Ag、HBs Ab、HBe Ag、HBe Ab、HBc Ab的阳性率分别6.6%、59.0%、0.5%、8.0%、21.2%。SLE组阳性率分别0.6%,、41.3%、0.0%、1.4%、2.9%;RA组的阳性率分别7.1%、57.8%、1.0%、6.8%、16.3%,结果 RA患者HBV感染和普通人群相似,SLE患者的HBV各项指标阳性率均低于RA患者(P=0.001)、也明显低于普通人群。HBV感染与SLE/RA相关临床指标、自身抗体的关系分析,结果显示差异无统计学意义(P>0.05)。结论 RA患者和普通人群HBV感染相似,而SLE的HBV感染明显低于RA患者和普通人群,SLE患者在使用糖皮质激素等免疫抑制剂时HBV感染风险不高,是否需要与RA一样常规推荐使用HBV疫苗、或HBV感染患者常规使用抗病毒药物,值得进一步研究。 Objective To investigate the prevalence of hepatitis B virus( HBV) infection in patients with systemic lupus erythematosus( SLE) and rheumatoid arthritis( RA). Methods Totally 346 patients with SLE and 294 patients with RA were recruited from the Department of Rheumatology and Immunology in the First Affiliated Hospital of Anhui Medical University from January 2015 to December2015. Clinical and laboratory parameters such as HBV serological markers data were recorded. Results In the control group,the positive rates of HBs Ag,HBs Ab,HBe Ag,HBe Ab and HBc Ab were 6. 6%,59. 0%,0. 5%,8. 0% and 21. 2%,respectively. The positive rates of them in SLE group were 0. 6%,41. 3%,0. 0%,1. 4% and 2. 9%,respectively while the positive rates of them in RA group were 7. 1%,57. 8%,1. 0 %,6. 8% and 16. 3%,respectively. The prevalence of HBV infection in patients with RA was similar to that of normal population. All the indicators of HBV infection in patients with SLE were significantly lower than those in patients with RA( P= 0. 001) and normal subjects. The indicators of HBV infection were not significantly associated with clinical parameters and autoantibody in patients with SLE and RA( all P 〉0. 05). Conclusions The prevalence of HBV infection in patients with SLE was lower than that of normal subjects and patients with RA. The prevalence of HBV infection in patients with RA was similar to that of normal subjects.. Further study will be needed of whether HBV vaccine should be routinely recommended or patients with HBV infection should use routinely antiviral drugs,when the use of glucocorticoid and immunosuppressant results in low prevalence of HBV infection.
出处 《安徽医药》 CAS 2016年第7期1287-1291,共5页 Anhui Medical and Pharmaceutical Journal
基金 国家自然科学基金资助项目(81401291)
关键词 乙型肝炎病毒 红斑狼疮 系统性 关节炎 类风湿 Hepatitis B virus Lupus Erythematosus Systemic Arthritis Rheumatoid
  • 相关文献

参考文献3

二级参考文献38

  • 1Wei Zhang,Bei Yue,Gui-Qiang Wang,Shu-Lan Lu the Department of Infectious Dispeases, Ruijing Hospital, Shanghai Second Medical University, Shanghai 200025, China Department of Intectious Diseases, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China.Serum and ascites levels of macrophage migration inhibitory factor, TNF-α and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2002,1(4):577-580. 被引量:18
  • 2蔡茹艺,卫建平,张小琴,吴丽然,王晨,姚舒蕾.乙型肝炎病毒感染与狼疮肾炎肾小管间质病变的研究[J].中华风湿病学杂志,2007,11(10):604-606. 被引量:3
  • 3Niewold TB,Swedler WI.Systemic lupus erythematosus arising duringinterferon-alpha therapy for cryoglobulinemic vasculitis associated withhepatitis C.Clin Rheumatol,2005,24:178-181.
  • 4Ho V,Mclean A,Terry S.Severe systemic lupus erythematosus in-duced by antiviral treatment for hepatitis C.J Clin Rheumatol,2008,14:166-168.
  • 5Y1lmaz S,Cimen KA.Pegylated interferon alfa-2βinduced lupus in apatient with chronic hepatitis B virus infection:case report.Clin Rheu-matol,2009,28:1241-1243.
  • 6Koutouzov S,Mathian A,Dalloul A.Type-Ⅰinterferons and systemiclupus erythematosus.Autoimmun Rev,2006,5:554-562.
  • 7Wilson LE,Widman D,Dikman SH,et al.Autoimmune disease com-plicating antiviral therapy for hepatitis C virus infection.Semin Arthri-tis Rheum,2002,32:163-173.
  • 8Touzot M,Touzot F,Galicier L,et al.Polyarthritis and anemia in a he-modialysis patient:systemic lupus erythematosus following treatmentwith interferon alpha.Clin Nephrol,2010,73:318-320.
  • 9Fukuyama S,Kajiwara E,Suzuki N,et al.Systemic lupus erythemato-sus after alpha-interferon therapy for chronic hepatitis C:a case reportand review of the literature.Am J Gastroenterol,2000,95:310-312.
  • 10Onishi S,Nagashima T,Kimura H,et al.Systemic lupus erythematosusand Sjgren's syndrome induced in a case by interferon-alpha used forthe treatment of hepatitis C.Lupus,2010,19:753-755.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部